Literature DB >> 11179749

Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D(3): CYP27 in epidermis completes the set of essential vitamin D(3)-hydroxylases.

M Schuessler1, N Astecker, G Herzig, G Vorisek, I Schuster.   

Abstract

The current understanding of the vitamin D(3) system shows skin as the unique site of vitamin D(3) production and liver is thought to be the main site of conversion to 25(OH)D(3). Skin is capable of activating 25(OH)D(3) via 1alpha-hydroxylation and the resulting 1alpha,25(OH)(2)D(3) plays a role in epidermal homeostasis in normal and diseased skin. It also rapidly up-regulates the major vitamin D(3) metabolizing enzyme 24-hydroxylase at the mRNA level, which is an established indicator for 1alpha,25(OH)(2)D(3)-presence. We investigated the capability of primary human keratinocytes to produce 25(OH)D(3) and subsequent metabolites from vitamin D(3). Thus, by orchestrating the entire system of production, activation and inactivation, skin could be independent of other organs in supply of hormonally active vitamin D(3). First, we demonstrated substantial conversion of (3)H-D(3) to (3)H-25(OH)D(3) in primary human keratinocytes. 25-Hydroxylation was slow, followed first order rate kinetics and was not saturable under our experimental conditions. Then we showed expression of 25-hydroxylase mRNA and compared it to levels of 1alpha-hydroxylase and 24-hydroxylase. Pre-incubation with vitamin D(3) resulted in dose and time dependent up-regulation of 24-hydroxylase mRNA, whereas neither 1alpha-hydroxylase nor 25-hydroxylase expression was affected. Since both, D(3) and 25(OH)D(3) are lacking intrinsic 24-hydroxylase-inducing capacity, up-regulation had to be the consequence of a two-step activation process via 25-hydroxylation and subsequent 1alpha-hydroxylation. 24-Hydroxylase-activities closely followed the corresponding mRNA levels. When 1alpha,25(OH)(2)D(3) itself or its precursor 25(OH)D(3) were used as inducing agents, 24-hydroxylase mRNA and enzyme activity followed a transient time course. In contrast, induction observed with physiological doses of D(3) remained high, even after a 20 h-time period. These differing characteristics may be explained by the slow but constant formation of 1alpha,25(OH)(2)D(3) from a large reservoir of D(3) in the target cell, providing constant supplies for induction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179749     DOI: 10.1016/s0039-128x(00)00229-4

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  16 in total

1.  The skin as an endocrine organ.

Authors:  Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2009-09

Review 2.  Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes.

Authors:  Bruce W Hollis; Carol L Wagner
Journal:  J Clin Endocrinol Metab       Date:  2013-10-08       Impact factor: 5.958

Review 3.  Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications.

Authors:  Carol L Wagner; Bruce W Hollis; Kalliopi Kotsa; Hana Fakhoury; Spyridon N Karras
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

4.  Metabolism of cholesterol, vitamin D3 and 20-hydroxyvitamin D3 incorporated into phospholipid vesicles by human CYP27A1.

Authors:  Elaine W Tieu; Wei Li; Jianjun Chen; Donna M Baldisseri; Andrzej T Slominski; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2011-12-24       Impact factor: 4.292

5.  CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders.

Authors:  Xiuying Bai; Dengshun Miao; Sophia Xiao; Dinghong Qiu; René St-Arnaud; Martin Petkovich; Ajay Gupta; David Goltzman; Andrew C Karaplis
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

6.  Fundamental questions to sun protection: A continuous education symposium on vitamin D, immune system and sun protection at the University of Zürich.

Authors:  Margret Schlumpf; Jörg Reichrath; Bodo Lehmann; Hekla Sigmundsdottir; Laurence Feldmeyer; Günther Fl Hofbauer; Walter Lichtensteiger
Journal:  Dermatoendocrinol       Date:  2010-01

7.  Vitamin D metabolism and action in human bone marrow stromal cells.

Authors:  Shuanhu Zhou; Meryl S LeBoff; Julie Glowacki
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

Review 8.  Vitamin D metabolism in human bone marrow stromal (mesenchymal stem) cells.

Authors:  Shuo Geng; Shuanhu Zhou; Zhenggang Bi; Julie Glowacki
Journal:  Metabolism       Date:  2013-01-30       Impact factor: 8.694

9.  The vitamin D3 transcriptomic response in skin cells derived from the Atlantic bottlenose dolphin.

Authors:  Blake C Ellis; Sebastiano Gattoni-Celli; Annalaura Mancia; Mark S Kindy
Journal:  Dev Comp Immunol       Date:  2009-03-21       Impact factor: 3.636

Review 10.  Cytochromes p450 and skin cancer: role of local endocrine pathways.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Igor Semak; Blazej Zbytek; Alexander Pisarchik; Wei Li; Jordan Zjawiony; Robert C Tuckey
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.